Tobias E. Erlanger
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial.
Journal: EClinicalMedicine
Published: October 30, 2023
Prospects and Perspectives of Health Impact Assessment: A Systematic Review of the Peer-Reviewed Literature From June 2007 to January 2023.
Journal: Public health reviews
Published: September 19, 2023
Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Journal: EClinicalMedicine
Published: October 26, 2022
Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)-a structured summary of a study protocol for a randomized controlled study.
Journal: Trials
Published: January 30, 2022
Ninety-day outcome of patients with severe COVID-19 treated with tocilizumab - a single centre cohort study.
Journal: Swiss medical weekly
Published: August 10, 2021
Validation of the Index for Facial Angiofibromas: A new scoring tool to assess facial angiofibromas in the tuberous sclerosis complex.
Journal: Journal of the American Academy of Dermatology
Published: July 11, 2021
Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial).
Journal: Trials
Published: September 04, 2020
Primary Transverse Closure Compared to Open Wound Treatment for Primary Pilonidal Sinus Disease in Children.
Journal: Children (Basel, Switzerland)
Published: August 19, 2020
Last Updated: 09/26/2026